Literature DB >> 33420592

The acute effects of classic psychedelics on memory in humans.

C J Healy1.   

Abstract

RATIONALE: Memory plays a central role in the psychedelic experience. The spontaneous recall and immersive reliving of autobiographical memories has frequently been noted by researchers and clinicians as a salient phenomenon in the profile of subjective effects of classic psychedelic drugs such as psilocybin, LSD, and ayahuasca. The ability for psychedelics to provoke vivid memories has been considered important to their clinical efficacy.
OBJECTIVE: This review aims to examine and aggregate the findings from experimental, observational, and qualitative studies on the acute modulation of memory by classic psychedelics in humans.
METHOD: A literature search was conducted using PubMed and PsycInfo as well as manual review of references from eligible studies. Publications reporting quantitative and/or qualitative findings were included; animal studies and case reports were excluded.
RESULTS: Classic psychedelics produce dose-dependently increasing impairments in memory task performance, such that low doses produce no impairment and higher doses produce increasing levels of impairment. This pattern has been observed in tasks assessing spatial and verbal working memory, semantic memory, and non-autobiographical episodic memory. Such impairments may be less pronounced among experienced psychedelic users. Classic psychedelics also increase the vividness of autobiographical memories and frequently stimulate the recall and/or re-experiencing of autobiographical memories, often memories that are affectively intense (positively or negatively valenced) and that had been avoided and/or forgotten prior to the experience.
CONCLUSIONS: Classic psychedelics dose-dependently impair memory task performance but may enhance autobiographical memory. These findings are relevant to the understanding of psychological mechanisms of action of psychedelic-assisted psychotherapy.

Entities:  

Keywords:  Autobiographical memory,; Episodic memory,; Memory,; Psychedelic-assisted psychotherapy; Psychedelics,; Recovered memory; Semantic memory,; Working memory,

Mesh:

Substances:

Year:  2021        PMID: 33420592     DOI: 10.1007/s00213-020-05756-w

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  61 in total

Review 1.  Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.

Authors:  Frederick S Barrett; Roland R Griffiths
Journal:  Curr Top Behav Neurosci       Date:  2018

2.  L.S.D. 25 as an aid in psychotherapy; preliminary report of a new drug.

Authors:  A K BUSCH; W C JOHNSON
Journal:  Dis Nerv Syst       Date:  1950-08

3.  Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users.

Authors:  José Carlos Bouso; Josep Maria Fábregas; Rosa Maria Antonijoan; Antoni Rodríguez-Fornells; Jordi Riba
Journal:  Psychopharmacology (Berl)       Date:  2013-06-21       Impact factor: 4.530

4.  Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.

Authors:  Frederick S Barrett; Theresa M Carbonaro; Ethan Hurwitz; Matthew W Johnson; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2018-07-30       Impact factor: 4.530

5.  Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.

Authors:  Michael P Bogenschutz; Alyssa A Forcehimes; Jessica A Pommy; Claire E Wilcox; P C R Barbosa; Rick J Strassman
Journal:  J Psychopharmacol       Date:  2015-01-13       Impact factor: 4.153

6.  Theoretical aspects of L.S.D. therapy.

Authors:  J Buckman
Journal:  Int J Soc Psychiatry       Date:  1967

7.  Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers.

Authors:  Anya K Bershad; Scott T Schepers; Michael P Bremmer; Royce Lee; Harriet de Wit
Journal:  Biol Psychiatry       Date:  2019-06-03       Impact factor: 13.382

Review 8.  Therapeutic Applications of Classic Hallucinogens.

Authors:  Michael P Bogenschutz; Stephen Ross
Journal:  Curr Top Behav Neurosci       Date:  2018

Review 9.  The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas.

Authors:  R L Carhart-Harris; K J Friston
Journal:  Brain       Date:  2010-02-28       Impact factor: 13.501

Review 10.  Psychedelics: Where we are now, why we got here, what we must do.

Authors:  Sean J Belouin; Jack E Henningfield
Journal:  Neuropharmacology       Date:  2018-02-21       Impact factor: 5.250

View more
  8 in total

Review 1.  Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.

Authors:  Albert Garcia-Romeu; Sean Darcy; Hillary Jackson; Toni White; Paul Rosenberg
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 2.  Psychedelic-inspired approaches for treating neurodegenerative disorders.

Authors:  Hannah N Saeger; David E Olson
Journal:  J Neurochem       Date:  2021-12-05       Impact factor: 5.546

3.  Using Psychedelics With Therapeutic Intent Is Associated With Lower Shame and Complex Trauma Symptoms in Adults With Histories of Child Maltreatment.

Authors:  C J Healy; Kellie Ann Lee; Wendy D'Andrea
Journal:  Chronic Stress (Thousand Oaks)       Date:  2021-07-11

Review 4.  Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.

Authors:  John R Kelly; Claire M Gillan; Jack Prenderville; Clare Kelly; Andrew Harkin; Gerard Clarke; Veronica O'Keane
Journal:  Front Psychiatry       Date:  2021-12-17       Impact factor: 4.157

Review 5.  Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs.

Authors:  Enzo Tagliazucchi
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

Review 6.  Psychedelic Cognition-The Unreached Frontier of Psychedelic Science.

Authors:  Maria Bălăeţ
Journal:  Front Neurosci       Date:  2022-03-15       Impact factor: 4.677

Review 7.  Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.

Authors:  Robertas Strumila; Bénédicte Nobile; Laura Korsakova; Aiste Lengvenyte; Emilie Olie; Jorge Lopez-Castroman; Sébastien Guillaume; Philippe Courtet
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-24

Review 8.  Catalysts for change: the cellular neurobiology of psychedelics.

Authors:  Matthew I Banks; Zarmeen Zahid; Nathan T Jones; Ziyad W Sultan; Cody J Wenthur
Journal:  Mol Biol Cell       Date:  2021-06-01       Impact factor: 4.138

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.